Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Catabasis Pharma (CATB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,928
  • Shares Outstanding, K 23,080
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,060 K
  • 36-Month Beta 1.20
  • Price/Sales 147.71
  • Price/Cash Flow N/A
  • Price/Book 2.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.15 +40.43%
on 02/09/18
2.38 -32.14%
on 02/13/18
+0.09 (+5.56%)
since 01/19/18
3-Month
1.15 +40.43%
on 02/09/18
2.38 -32.14%
on 02/13/18
-0.10 (-5.56%)
since 11/20/17
52-Week
1.09 +48.17%
on 07/21/17
3.78 -57.28%
on 10/04/17
+0.37 (+29.20%)
since 02/17/17

Most Recent Stories

More News
Today's Research Reports on Trending Tickers: Catabasis Pharmaceuticals and ImmunoCellular Therapeutics

NEW YORK, NY / ACCESSWIRE / February 14, 2018 / Strong performances from banking and technology stocks helped lift the markets further into the green on Tuesday. The Dow Jones Industrial Average gained...

IMUC : 0.24 (unch)
CATB : 1.55 (-3.13%)
Catabasis Pharmaceuticals Reports Edasalonexent Preserved Muscle Function and Substantially Slowed Duchenne Muscular Dystrophy Disease Progression Through More Than One Year of Treatment

-- Single Global Phase 3 Trial Expected to Begin in First Half of 2018 --

CATB : 1.55 (-3.13%)
Amgen Announces Acceptance of MAA for Evenity in Europe

Amgen's (AMGN) regulatory application seeking approval for Evenity as a treatment of osteoporosis gets EMA's acceptance.

CLDX : 2.36 (+0.43%)
CATB : 1.55 (-3.13%)
MRK : 54.99 (-2.31%)
AMGN : 182.21 (-0.73%)
Ultragenyx Announces Interim Data from Early Stage Study

Ultragenyx (RARE) announces data from phase I/II study on its AAV gene therapy candidate, DTX301, demonstrating normalization of ureagenesis in patients with ornithine transcarbamylase deficiency.

CLDX : 2.36 (+0.43%)
CATB : 1.55 (-3.13%)
RARE : 49.09 (+4.18%)
ANTH : 1.80 (+6.51%)
5 Small-Cap Stocks Set to Explode Higher in 2018

Small caps are poised to surge in 2018 given tax cuts and improving domestic economy.

CATB : 1.55 (-3.13%)
BBG : 5.45 (+1.68%)
TITN : 19.48 (+0.57%)
DGICA : 16.42 (-2.90%)
BREW : 18.65 (+0.27%)
Santhera Pharmaceuticals, Summit Therapeutics, Catabasis Pharmaceuticals and Duchenne UK to host Duchenne Muscular Dystrophy Awareness Day

Santhera Pharmaceuticals (SIX:SANN), Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), Catabasis Pharmaceuticals (NASDAQ:CATB) and Duchenne UK are pleased to announce a collaboration to host a Duchenne Muscular...

CATB : 1.55 (-3.13%)
SMMT : 11.95 (+2.31%)
Santhera Pharmaceuticals, Summit Therapeutics, Catabasis Pharmaceuticals and Duchenne UK to host Duchenne Muscular Dystrophy Awareness Day

Santhera Pharmaceuticals Holding AG / Santhera Pharmaceuticals, Summit Therapeutics, Catabasis Pharmaceuticals and Duchenne UK to host Duchenne Muscular Dystrophy Awareness Day . Processed and transmitted...

CATB : 1.55 (-3.13%)
Is GW Pharma (GWPH) Likely to Beat Earnings Estimates in Q4?

GW Pharma (GWPH) will report its fiscal fourth-quarter results next week. Investors focus is expected to be on commercialization plan for Epidiolex.

SGMO : 23.25 (-0.21%)
LGND : 155.71 (-0.91%)
CATB : 1.55 (-3.13%)
GWPH : 131.48 (+0.36%)
Catabasis Pharmaceuticals to Present at 29th Annual Piper Jaffray Healthcare Conference

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present an overview...

CATB : 1.55 (-3.13%)
Analysis: Positioning to Benefit within Catabasis, Flowserve, MGIC Investment, Arrowhead, Silver Spring, and Live Nation - Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Catabasis Pharmaceuticals,...

MTG : 14.26 (-0.90%)
ARWR : 5.73 (+2.87%)
CATB : 1.55 (-3.13%)
LYV : 47.35 (+0.85%)
FLS : 45.49 (+3.27%)
SSNI : 16.26 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of therapeutics for treatment of inflammatory, immunological and metabolic diseases. Its product development pipeline includes CAT-1004, CAT-2000 series including CAT-2054...

See More

Key Turning Points

2nd Resistance Point 1.96
1st Resistance Point 1.78
Last Price 1.55
1st Support Level 1.41
2nd Support Level 1.22

See More

52-Week High 3.78
Fibonacci 61.8% 2.75
Fibonacci 50% 2.43
Fibonacci 38.2% 2.12
Last Price 1.55
52-Week Low 1.09

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.